Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says




googletag.cmd.push(function() googletag.display('maavaron.ros.ctech');
googletag.pubads().addEventListener('slotRenderEnded', function(event)
if (event.slot.getSlotElementId() == 'maavaron.ros.ctech')
if (event.isEmpty)
document.getElementById('maavaron.ros.ctech').style.display = 'none';


);
);
try
if (maavaronshow==0)
console.log("maavaron hidden" + localStorage.maavaronView);
$('#siteOverlay').hide();


catch(err)
$('#siteOverlay').hide();











  • About

  • Buzz

  • Startups

  • 24/7



  • Search







  • cleanSearch



  • Accesabillty







googletag.cmd.push(function() googletag.display('prime.ctech'); );




Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month

Dror Reich 12:0226.08.18

TAGS:
  • Teva

  • Mylan

  • EpiPen


Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.

 



For daily updates, subscribe to our newsletter by clicking here.




 
Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.

 




Students. Photo: Shutterstock Students. Photo: Shutterstock


googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



 


 

Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.

 




jQuery(document).ready( function()
jQuery('.ArticlePromotionMor').click(function()
GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
);
);
Related stories:

  • Teva Wins FDA Approval for First Generic EpiPen

  • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

  • Teva's American Dream Boat is Sinking




googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );



 

Teva was down 3.28% on NYSE on Friday market close.







googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );










Cancel
Send


    To all comments






    Buzz
    Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
    10 Israeli Startups that Are Looking For U.S. Investments
    22.03.2018 Hagar Ravet and Omer Kabir

    MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
    31.07.2018 Lilach Baumer


    Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
    16.03.2018 Hagar Ravet



    Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
    18.02.2018 Amarelle Wenkert


    Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
    05.03.2018 Amarelle Wenkert


    Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
    01.02.2018 Lilach Baumer






    googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );


    Recently Read

    Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments

    Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups

    Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



    googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );


    Recommended videos

    A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car

    Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



    googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );




    googletag.cmd.push(function() googletag.display('special.prime.ros.ctech'); );





    Ctech Logo





    Twitter
    Twitter









    Contact Us
    Contact Us







    Rss
    Rss








    About CTech
    Terms of Use
    Privacy Policy






    Developed by



    UI & UX by Basch_Interactive




    var axel = Math.random() + '';
    var a = axel * 10000000000000;
    document.write('');





    if (window.location.href.toLowerCase().indexOf('lobby')>-1)
    document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
    document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
    document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));









    • About

    • Buzz

    • Startups

    • 24/7



    • Search







    • cleanSearch



    • Accesabillty












    • About

    • Buzz

    • Startups

    • 24/7



    • Search







    • cleanSearch



    • Accesabillty



















    bycalcalist logo








    • Homepage
    • News
    .TrajectoryTable border:0px solid #dbdcd7; width:900px;.rss-linkWrp line-height: 27px !important;.traj-photoCalcalist font-size: 28px;margin: 10px 7px 11px 0; .traj-photoCalcalist-icon margin-top: 9px;.trajAlert margin-top: 0px !important; #TrajectoryMainImg img margin: 7px 0 3px 28px !important;border:0;.art-trajectory float:left;height:18px;.traj-bc margin-bottom:0 !important;.art-trajectory .traj-bc display:none;margin-bottom: 0 !important; .art-trajectory .traj-wrp width: 1210px !important ;overflow: hidden !important;.art-trajectory .trajectoryTextf overflow:visible !important; .profile-right-wrp .trajectoryTextf display:none;.profile-right-wrp #TrajectoryMainImg display:none;.profile-right-wrp .traj-bc .TrajectoryTable a:hover text-decoration:underline;.headerStrip margin-bottom:8px;background-color:#fff;.headerStrip img border:0px;.trajectoryTextf width:900px;padding-top: 2px;.TrajectoryTable a color:#616161;display:inline-block;.TrajectoryTable a:hover text-decoration:none;#TrajectoryMainImg display:none;#TrajectoryMainImg img margin:3px 0 3px 28px;border:0;span#p_alertfont-size:13px;margin-right: 5px;vertical-align: 3px;span#p_alert img margin-top: -2px;.traj-bc float:left;margin-top:-2px;.traj-bc ul margin: 0;display: inline;.traj-bc li display: inline-block;font-size: 11px;float: left;.traj-bc li::after content:' >'; margin-left:6px;.traj-bc li:last-child::after content:none;.traj-bc li a color:#969696;text-decoration:none;font-size: 13px;.trajAlert margin-top:5px;border:0; a.rss-linkWrp overflow: hidden;height: 23px;line-height: 27px;display: inline-block;direction: rtl;
    @media all and (max-width: 1240px)
    .TrajectoryTable width: 550px;
    div.header-user-profile width: 890px;
    .art-trajectory .TrajectoryTable width: 890px;overflow: hidden;margin-right: 57px;



    $(document).ready(function()
    if (navigator.appName == 'Microsoft Internet Explorer')
    $('.trajectoryTextf').removeClass('OpenSansRegular');

    );

    function openWin(url,title,attrib) wref=window.open(url,title,attrib);if(MSIE_VER()>=5)wref.focus()
    function openInnewWindow(url,width,height,toolbar)
    if(toolbar==1)
    openWin(url,'Calcalist','toolbar=yes,location=yes,directories=yes,status=yes,menubar=yes,scrollbars=yes,resizable=yes,width='+width+',height='+height)
    else
    openWin(url,'Calcalist','toolbar=no,location=no,directories=no,status=yes,menubar=no,scrollbars=no,movable=yes,resizable=yes,width='+width+',height='+height)








    • Homepage
    • News

















    googletag.cmd.push(function() googletag.display('prime.ctech'); );




    googletag.cmd.push(function() googletag.display('prime.ctech'); );



    googletag.cmd.push(function() googletag.display('prime.ctech'); );





    Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

    The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month

    Dror Reich 12:0226.08.18

    TAGS:
    • Teva

    • Mylan

    • EpiPen


    Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.

     



    For daily updates, subscribe to our newsletter by clicking here.




     
    Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.

     




    Students. Photo: Shutterstock Students. Photo: Shutterstock


    googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



     


     

    Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.

     




    jQuery(document).ready( function()
    jQuery('.ArticlePromotionMor').click(function()
    GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
    );
    );
    Related stories:

    • Teva Wins FDA Approval for First Generic EpiPen

    • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

    • Teva's American Dream Boat is Sinking




    googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );



     

    Teva was down 3.28% on NYSE on Friday market close.







    googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );










    Cancel
    Send


      To all comments






      Buzz
      Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
      10 Israeli Startups that Are Looking For U.S. Investments
      22.03.2018 Hagar Ravet and Omer Kabir

      MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
      31.07.2018 Lilach Baumer


      Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
      16.03.2018 Hagar Ravet



      Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
      18.02.2018 Amarelle Wenkert


      Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
      05.03.2018 Amarelle Wenkert


      Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
      01.02.2018 Lilach Baumer






      googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );


      Recently Read

      Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments

      Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups

      Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



      googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );


      Recommended videos

      A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car

      Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



      googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );








      Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

      The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month

      Dror Reich 12:0226.08.18

      TAGS:
      • Teva

      • Mylan

      • EpiPen


      Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.

       



      For daily updates, subscribe to our newsletter by clicking here.




       
      Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.

       




      Students. Photo: Shutterstock Students. Photo: Shutterstock


      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



       


       

      Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.

       




      jQuery(document).ready( function()
      jQuery('.ArticlePromotionMor').click(function()
      GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
      );
      );
      Related stories:

      • Teva Wins FDA Approval for First Generic EpiPen

      • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

      • Teva's American Dream Boat is Sinking




      googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );



       

      Teva was down 3.28% on NYSE on Friday market close.







      Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

      The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month

      Dror Reich 12:0226.08.18

      TAGS:
      • Teva

      • Mylan

      • EpiPen


      Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.

       



      For daily updates, subscribe to our newsletter by clicking here.




       
      Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.

       




      Students. Photo: Shutterstock Students. Photo: Shutterstock


      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



       


       

      Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.

       




      jQuery(document).ready( function()
      jQuery('.ArticlePromotionMor').click(function()
      GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
      );
      );
      Related stories:

      • Teva Wins FDA Approval for First Generic EpiPen

      • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

      • Teva's American Dream Boat is Sinking




      googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );



       

      Teva was down 3.28% on NYSE on Friday market close.


      Dror Reich 12:0226.08.18



      TAGS:
      • Teva

      • Mylan

      • EpiPen




      Earlier this month, the U.S. Food and Drug Administration awarded Teva Pharmaceutical Industries Ltd. approval to market the first generic version of Mylan NV’s EpiPen auto-injectors. But now, amidst product shortages, SunTrust Robinson Humphrey analyst John Boris says Teva’s EpiPen—the price of which has yet to be announced—will not hit the market in time for the start of the school year.

       



      For daily updates, subscribe to our newsletter by clicking here.




       
      Cited in a Friday report by MarketWatch, Boris said that wholesalers expect at least two months of waiting before Teva’s generic version could be found on the shelves. In the U.S., the first day of school usually falls after Labor Day, on the first Monday of September, but some districts open in August. Deficiencies in the market could hinder both schools and parents looking to stock up.

       




      Students. Photo: Shutterstock Students. Photo: Shutterstock


      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



       


       

      Last week, Mylan announced extended expiration dates for some EpiPen batches in coordination with the FDA, to prepare for growing demand ahead of the school year. Mylan also stated it expects supply to stabilize in the fourth quarter of 2018.

       




      jQuery(document).ready( function()
      jQuery('.ArticlePromotionMor').click(function()
      GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
      );
      );
      Related stories:

      • Teva Wins FDA Approval for First Generic EpiPen

      • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

      • Teva's American Dream Boat is Sinking




      googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );



       

      Teva was down 3.28% on NYSE on Friday market close.




      Students. Photo: Shutterstock Students. Photo: Shutterstock


      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );





      Students. Photo: Shutterstock Students. Photo: Shutterstock



      Students. Photo: Shutterstock Students. Photo: Shutterstock



      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );



      googletag.cmd.push(function() googletag.display('ad.above.picture.article.ros.ctech'); );




      jQuery(document).ready( function()
      jQuery('.ArticlePromotionMor').click(function()
      GA_report_local("Article_Promotion_Mor","Large",jQuery(this).attr('href'));
      );
      );
      Related stories:

      • Teva Wins FDA Approval for First Generic EpiPen

      • Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

      • Teva's American Dream Boat is Sinking




      googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );




      Related stories:






      googletag.cmd.push(function() googletag.display('more.artice.ros.ctech'); );
















      googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );



      googletag.cmd.push(function() googletag.display('strip.ros.ctech'); );










      Cancel
      Send


        To all comments














        Cancel
        Send


          To all comments












          Cancel
          Send


            To all comments











            Cancel
            Send




            Cancel
            Send


            To all comments



            To all comments


            Buzz
            Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
            10 Israeli Startups that Are Looking For U.S. Investments
            22.03.2018 Hagar Ravet and Omer Kabir

            MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
            31.07.2018 Lilach Baumer


            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
            16.03.2018 Hagar Ravet



            Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
            18.02.2018 Amarelle Wenkert


            Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
            05.03.2018 Amarelle Wenkert


            Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
            01.02.2018 Lilach Baumer





            Buzz
            Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
            10 Israeli Startups that Are Looking For U.S. Investments
            22.03.2018 Hagar Ravet and Omer Kabir

            MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
            31.07.2018 Lilach Baumer


            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
            16.03.2018 Hagar Ravet



            Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
            18.02.2018 Amarelle Wenkert


            Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
            05.03.2018 Amarelle Wenkert


            Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
            01.02.2018 Lilach Baumer





            Buzz


            Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
            10 Israeli Startups that Are Looking For U.S. Investments
            22.03.2018 Hagar Ravet and Omer Kabir


            Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen
            10 Israeli Startups that Are Looking For U.S. Investments
            22.03.2018 Hagar Ravet and Omer Kabir


            Investors meeting with entrepreneurs at Meet & Pitch. Photo: Orel Cohen


            10 Israeli Startups that Are Looking For U.S. Investments


            22.03.2018 Hagar Ravet and Omer Kabir





            MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
            31.07.2018 Lilach Baumer


            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
            16.03.2018 Hagar Ravet



            MyMM Chinese Online Fashion Retailer MyMM to Implement Image Search
            31.07.2018 Lilach Baumer



            31.07.2018 Lilach Baumer


            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky
            16.03.2018 Hagar Ravet



            16.03.2018 Hagar Ravet



            Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
            18.02.2018 Amarelle Wenkert


            Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
            05.03.2018 Amarelle Wenkert


            Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
            01.02.2018 Lilach Baumer




            Device by Perflow. Photo: Perflow Neurovascular Medical Startup Perflow Medical Receives $12 Million in Funding
            18.02.2018 Amarelle Wenkert



            18.02.2018 Amarelle Wenkert


            Nucleai CEO Avi Veidman. Photo: PR AI Cancer Detection Startup Nucleai Raises $5 Million
            05.03.2018 Amarelle Wenkert



            05.03.2018 Amarelle Wenkert


            Food (illustration). Photo: Anatoly michaelo Aleph Venture Capital Leads $15 Million Round for AI-Based Catering Startup Platterz
            01.02.2018 Lilach Baumer



            01.02.2018 Lilach Baumer




            googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );


            Recently Read

            Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments

            Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups

            Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



            googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );


            Recommended videos

            A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car

            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



            googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );






            googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );



            googletag.cmd.push(function() googletag.display('big.box1.ros.ctech'); );


            Recently Read

            Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments

            Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups

            Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



            Recently Read

            Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments

            Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups

            Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



            Recently Read


            Saar Wilf. Photo: Orel CohenSaar Wilf’s Bid to Rid the World of Clunky Online Payments


            Lemonade co-founders Shai Wininger and Daniel Schreiber. Photo: Ben KelmerCalcalist’s 2018 List of 50 Most Promising Israeli Startups


            Stephane Legar in the commercial. Photo: Ohad RomanoHit Commercial Song Jabs Israelis (Almost) Everywhere It Hurts



            googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );



            googletag.cmd.push(function() googletag.display('sopranos.1.ros.ctech'); );


            Recommended videos

            A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car

            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



            Recommended videos

            A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car

            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



            Recommended videos


            A City Transformer vehicle. Photo: PR Tired of Looking for Parking, Israeli Entrepreneurs Develop Foldable Car


            Aerodrome CEO Roy Degani at the Mind the Tech conference. Photo: Orel Cohen Agritech Drone Startup Aerodrome Monitors Crops From the Sky



            googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );



            googletag.cmd.push(function() googletag.display('big.box2.ros.ctech'); );






            googletag.cmd.push(function() googletag.display('special.prime.ros.ctech'); );







            Ctech Logo





            Twitter
            Twitter









            Contact Us
            Contact Us







            Rss
            Rss








            About CTech
            Terms of Use
            Privacy Policy






            Developed by



            UI & UX by Basch_Interactive




            var axel = Math.random() + '';
            var a = axel * 10000000000000;
            document.write('');





            if (window.location.href.toLowerCase().indexOf('lobby')>-1)
            document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
            document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
            document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));







            Ctech Logo





            Twitter
            Twitter









            Contact Us
            Contact Us







            Rss
            Rss








            About CTech
            Terms of Use
            Privacy Policy






            Developed by



            UI & UX by Basch_Interactive




            var axel = Math.random() + '';
            var a = axel * 10000000000000;
            document.write('');





            if (window.location.href.toLowerCase().indexOf('lobby')>-1)
            document.querySelector('*[id^="prime."]').parentElement.removeChild(document.querySelector('*[id^="prime."]'));
            document.getElementById('vilon').parentElement.removeChild(document.getElementById('vilon'));
            document.getElementById('siteOverlay').parentElement.removeChild(document.getElementById('siteOverlay'));







            Ctech Logo





            Twitter
            Twitter









            Contact Us
            Contact Us







            Rss
            Rss








            About CTech
            Terms of Use
            Privacy Policy






            Developed by



            UI & UX by Basch_Interactive





            Ctech Logo






            Twitter
            Twitter









            Contact Us
            Contact Us







            Rss
            Rss










            Twitter
            Twitter







            Twitter
            Twitter




            Twitter






            Facebook
            Facebook




            Facebook






            Newsletter





            Contact Us
            Contact Us







            Contact Us
            Contact Us




            Contact Us





            Rss
            Rss







            Rss
            Rss




            Rss




            About CTech
            Terms of Use
            Privacy Policy






            About CTech
            Terms of Use
            Privacy Policy









            Developed by



            UI & UX by Basch_Interactive


            The name of the pictureThe name of the pictureThe name of the pictureClash Royale CLAN TAG#URR8PPP
            -

            Popular posts from this blog

            Rothschild family

            Image
            "House of Rothschild" redirects here. For the film, see The House of Rothschild. For other uses, see Rothschild (disambiguation). Rothschild Jewish noble banking family Coat of arms granted to the Barons Rothschild in 1822 by Emperor Francis I of Austria Ethnicity Jewish Current region Western Europe (mainly United Kingdom, France, and Germany) [1] Etymology Rothschild (German): "red shield" Place of origin Frankfurter Judengasse, Frankfurt, Holy Roman Empire Founded 1760s (1577  ( 1577 ) ) Founder Mayer Amschel Rothschild (1744–1812) (Elchanan Rothschild, b. 1577) Titles List Freiherr von Rothschild (1822) Baronet, of Tring Park (1847) Baron Rothschild (1885) Traditions Judaism, Goût Rothschild Motto Concordia, Integritas, Industria (English: Harmony, Integrity, Industry ) Estate(s) List British properties Château de Ferrières Palais Rothschild Cadet branches List Austrian branch English branch French branch Neapolitan branch A Rothschild house,...
            Read more

            Cinema of Italy

            Image
            Cinema of Italy Some of the notable actors and filmmakers [a] No. of screens 3,217 (2011) [1]  • Per capita 5.9 per 100,000 (2011) [1] Main distributors Medusa Film (16.7%) Warner Bros. (13.8%) 20th Century Fox (13.7%) [2] Produced feature films (2013) [3] Total 167 Number of admissions (2013) [3] Total 97,380,572  • Per capita 1.50 (2012) [4] National films 30,208,422 (31.0%) Gross box office (2013) [3] Total €618 million National films €188 million (30.5%) The Cinema of Italy comprises the films made within Italy or by Italian directors. Since the development of the Italian film industry in the early 1900s, Italian filmmakers and performers have, at times, experienced both domestic and international success, and have influenced film movements throughout the world. As of 2014, Italian films have won 14 Academy Awards for Best Foreign Language Film, the most of any country, as well as 12 Palmes d'Or, the second-most ...
            Read more